中國復星競購葡萄牙醫院運營商

Chinese conglomerate Fosun has entered the bidding war for Espírito Santo Saúde, offering $580m for the Portuguese hospital operator.

中國綜合企業復星(Fosun)以5.8億美元的出價，加入到了對葡萄牙醫院運營商ESS(Espírito Santo Saúde)的競購戰中。

Fidelidade, the Portuguese insurer and a Fosun subsidiary, is offering 4.72 a share for the healthcare business, according to a statement to the Hong Kong stock exchange on Tuesday. The bid represents a premium of 31 per cent above the average share price over the previous six months, Fosun said. Shares in ESS closed at 4.70 in Lisbon on Monday.

根據週二遞交給香港證交所的一份聲明，葡萄牙保險公司、復星子公司Fidelidade提出以每股4.72歐元的價格收購ESS。復星表示，這一出價較過去6個月ESS的平均股價溢價31%。ESS股價週一在里斯本收於4.70歐元。

ESS is 51 per cent-owned by Espírito Santo group, the troubled family company that controls Portuguese lender Banco Espírito Santo.

陷入困境的家族企業Espírito Santo集團持有ESS 51%股權，這個家族企業還控股了葡萄牙銀行Banco Espírito Santo。

The offer from China’s largest privately held conglomerate trumps the previous top bid of 4.50 a share by Mexico’s Grupo Angeles. José de Mello Saúde – a local rival to ESS – has also submitted an offer for the business.

復星是中國最大私人持股綜合企業。它對ESS的出價超過了此前墨西哥公司Grupo Angeles每股4.50歐元的最高出價。ESS的本國競爭對手José de Mello Saúde也提出了收購報價。

Fosun took control of Fidelidade, Portugal’s largest insurer, this year in a 1bn deal that signalled its intention to build a long-term international presence.

復星今年斥資10億歐元控股葡萄牙最大保險公司Fidelidade，表明它構建長期國際影響力的意圖。

“Fosun deals increasingly need to be thought about in terms of portfolio optimisation as opposed to thinking it is making a quick punt,” said one analyst, who linked its interest in ESS to its participation in April in a TPG-led consortium that won the bidding for US-listed Chinese hospital chain Chindex.

一位分析人士表示：“復星的交易越來越追求投資組合的最優化，而不是快進快出的投機。”他認爲，復星對ESS的興趣與此前一筆交易有關——今年4月，復星曾加入由德州太平洋集團(TPG)牽頭的財團，成功收購在美國上市的中國醫院連鎖美中互利(Chindex)。